Antimicrobial Deck 4 Flashcards Preview

Nurs 5229 Clinical Pharmacotherapeutics > Antimicrobial Deck 4 > Flashcards

Flashcards in Antimicrobial Deck 4 Deck (13)
Loading flashcards...
1
Q

Fluoroquinolones
1st Generation

Treats

A

No longer availible

2
Q

2nd Generation
ciprofloxacin

Treats

A

Weak Gr +, Gr –
Pseudomonas

GU/UTI
Pseudomonas

3
Q

3rd Generation
levofloxacin

tREATS

A
Gr+, Gr‐
Atypicals
β lactamase
DRSP
± Anaerobes
± Pseudomonas

Respiratory
GU
Pseudomonas

4
Q

4th Generation
Moxifloxacin, gemifloxacin

Treats

A

Atypicals, β lactamase, ±
Pseudomonas
DRSP, ± MRSA, ± Anaerobes

Resp, skin

5
Q

Macrolides

Treats

A

Gr+ (SS) some Gr – (Neisseria,
H‐flu

Resp, Skin, Gu

6
Q

Ketolide
telithromycin

Treats

A

Gr+, Gr‐
Atypicals, DRSP

Resp

7
Q

Critical‐priority bacteria

A

– carbapenem‐resistant Acinetobacter baumannii and Pseudomonas aeruginosa
– carbapenem‐resistant and third‐generation cephalosporin‐resistant Enterobacteriaceae.

8
Q

High Priority

– Gram‐positive bacteria

A
  • Vancomycin‐resistantEnterococcus faecium

* meticillin‐resistant Staphylococcus aureus

9
Q

High Priority

community‐acquired infections

A
  • clarithromycin‐resistant Helicobacter pylori
  • fluoroquinolone‐resistant Campylobacter spp
  • Neisseria gonorrhoeae
  • Salmonella typhi
10
Q

Targeted therapies

A

‐ traditional antibiotics and antibodies that are active against a single pathogen, especially Staphylococcus aureus or Pseudomonas aeruginosa

11
Q

Adjunctive therapies

A

– including drugs that target virulence factors,
biofilm formation, immune system stimulation, modifying the
microbiome, and phages. All such approaches require an active antibiotic

12
Q

Potentiator

A

– an adjuvant drug, such as beta‐lactamase‐inhibitors or efflux pump inhibitors, improve the activity of an antibiotic by
inhibiting resistance determinants, either facilitating the
penetration or changing the sensitivity of the bacterial cell

13
Q

Polymyxins

A
– revival of the polymyxin class as viable approach
(Colistin)